Home > Insider Trading > Filing (0001181431-14-027721)

Filing Details

Accession Number:: 0001181431-14-027721
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-07-30 16:03:14
Reporting Period:: 2014-07-28

Filing Date:: 2014-07-30
Accepted Time:: 2014-07-30 16:03:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138639	Infinera Corp	INFN	Telephone & Telegraph Apparatus (3661)	770560433

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1399122	F David Welch	C/O Infinera Corporation 140 Caspian Court Sunnyvale CA 94089	President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-07-28	2,500	$9.08	334,479	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-07-28	5,000	$9.09	495,000	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-07-29	10,000	$9.00	679,493	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	553,750	Indirect	See Footnote
Common Stock	2,500	Indirect	See Footnote
Common Stock	14,132	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Employee Stock Option (Right to Buy)	$2.00	2016-08-08	50,000	50,000	Direct
Common Stock	Employee Stock Option (Right to Buy)	$2.00	2016-08-08	137,500	137,500	Direct
Common Stock	Employee Stock Option (Right to Buy)	$8.19	2016-11-23	75,000	75,000	Direct
Common Stock	Employee Stock Option (Right to Buy)	$7.61	2017-06-06	29,214	29,214	Direct
Common Stock	Employee Stock Option (Right to Buy)	$7.61	2017-06-06	101,342	101,342	Direct
Common Stock	Employee Stock Option (Right to Buy)	$7.61	2018-02-28	2,817	2,817	Direct
Common Stock	Employee Stock Option (Right to Buy)	$7.61	2018-02-28	81,683	81,683	Direct
Common Stock	Employee Stock Option (Right to Buy)	$7.11	2019-02-10	100,000	100,000	Direct
Common Stock	Employee Stock Option (Right to Buy)	$7.45	2019-08-10	150,000	150,000	Direct
Common Stock	Employee Stock Option (Right to Buy)	$8.58	2021-02-10	20,250	20,250	Direct
Common Stock	Employee Stock Option (Right to Buy)	$8.58	2021-02-10	60,750	60,750	Direct
Common Stock	Employee Stock Option (Right to Buy)	$8.58	2021-02-10	39,465	39,465	Direct
Common Stock	Employee Stock Option (Right to Buy)	$8.58	2021-02-10	41,535	41,535	Direct
Common Stock	Restricted Stock Units	$0.00		26,333	26,333	Direct
Common Stock	Restricted Stock Units	$0.00		71,250	71,250	Direct
Common Stock	Restricted Stock Units	$0.00		40,000	40,000	Direct
Common Stock	Restricted Stock Units	$0.00		48,000	48,000	Direct
Common Stock	Restricted Stock Units	$0.00		62,770	62,770	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-08-08	50,000	50,000	Direct
2016-08-08	137,500	137,500	Direct
2016-11-23	75,000	75,000	Direct
2017-06-06	29,214	29,214	Direct
2017-06-06	101,342	101,342	Direct
2018-02-28	2,817	2,817	Direct
2018-02-28	81,683	81,683	Direct
2019-02-10	100,000	100,000	Direct
2019-08-10	150,000	150,000	Direct
2021-02-10	20,250	20,250	Direct
2021-02-10	60,750	60,750	Direct
2021-02-10	39,465	39,465	Direct
2021-02-10	41,535	41,535	Direct
	26,333	26,333	Direct
	71,250	71,250	Direct
	40,000	40,000	Direct
	48,000	48,000	Direct
	62,770	62,770	Direct

Footnotes

Shares held directly by LRFA, LLC of which Dr. Welch is the sole managing member.
Shares held directly by The Welch Family Trust u/a dtd 04/03/1996 ("The Welch Family Trust").
Shares held directly by SEI Private Trust Company, Trustee of the Welch Family Heritage Trust I u/I dated 9/24/01.
Shares held directly by The Welch Group, L.P. of which Dr. Welch is the general partner ("The Welch Group").
Shares held directly by Dr. Welch as a trustee for his minor children. Dr. Welch disclaims beneficial ownership of the shares held in trust for his minor children, and this report shall not be deemed an admission that Dr. Welch is the beneficial owner of the shares held in trust for his minor children for purposes of Section 16 or for any other purpose.
The option is fully vested.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company").
The RSUs vest in three annual installments beginning on February 5, 2013.
The RSUs fully vest on December 31, 2014.
The RSUs vest in three annual installments beginning on February 5, 2014.
The RSUs vest in four annual installments beginning on August 5, 2014.
The RSUs vest in three annual installments beginning on May 5, 2015.
This sale was made in connection with Dr. Welch's Rule 10b5-1 Trading Plan for The Welch Family Trust, which was adopted on May 29, 2014.
This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $9.02 to $9.18 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.
This sale was made in connection with Dr. Welch's Rule 10b5-1 Trading Plan for The Welch Group, which was adopted on May 29, 2014.
This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $9.02 to $9.15 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.
This sale was made in connection with Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on May 24, 2013.
This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $9 to $9.01 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.